Interestingly, RUNX1 expression in COAD was higher than in normal samples, suggesting a poor prognosis in these patients, which seems to be inconsistent with the role of tumor suppressors in gastrointestinal malignancies. The gene discussed is RUNX1; the disease is colon adenocarcinoma.